|

Fenofibric acid Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Medical University of Vienna1

Indications

  • Rare CNS Tumor Recurrent1
  • ATRT Recurrent1
  • Ependymoma Recurrent1
  • Medulloblastoma Recurrent1
  • Cancer1

Chicago, Illinois1 trial

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Ann & Robert H. Lurie Children's Hospital of Chicago

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.